| scholarly article | Q13442814 |
| P2093 | author name string | Qing Huang | |
| Zhao Yang | |||
| Ning Su | |||
| Han-Qing Xu | |||
| Wei-Ling Fu | |||
| Dong Chen | |||
| Na Zhao | |||
| Kun Wei | |||
| Jun-Fu Huang | |||
| Guang-Jie Duan | |||
| P2860 | cites work | Species-specific identification of ruminant components contaminating industrial crude porcine heparin using real-time fluorescent qualitative and quantitative PCR. | Q50506498 |
| Competitive PCR for precise nucleic acid quantification. | Q50912906 | ||
| Quantitative method for specific nucleic acid sequences using competitive polymerase chain reaction with an alternately binding probe. | Q51077108 | ||
| Wild-type blocking polymerase chain reaction for detection of single nucleotide minority mutations from clinical specimens. | Q53660247 | ||
| Should oncologists be aware in their clinical practice of KRAS molecular analysis? | Q54391227 | ||
| Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer. | Q54585853 | ||
| Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies. | Q55043614 | ||
| Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients | Q57975214 | ||
| Using Predictive Biomarkers to Select Patients With Advanced Colorectal Cancer for Treatment With Epidermal Growth Factor Receptor Antibodies | Q61868110 | ||
| Clinical benefit of high-sensitivity KRAS mutation testing in metastatic colorectal cancer treated with anti-EGFR antibody therapy | Q84066832 | ||
| Sensitive detection of trace amounts of KRAS codon 12 mutations by a fast and novel one-step technique | Q85258181 | ||
| PCR-based methods for the enrichment of minority alleles and mutations | Q24657701 | ||
| Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations | Q24678861 | ||
| Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer | Q27851407 | ||
| Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer | Q27851456 | ||
| Enhanced specificity of TPMT*2 genotyping using unidirectional wild-type and mutant allele-specific scorpion primers in a single tube | Q28541963 | ||
| Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer | Q29616236 | ||
| WASP: a Web-based Allele-Specific PCR assay designing tool for detecting SNPs and mutations | Q33294098 | ||
| COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations | Q33689438 | ||
| The Taguchi methodology as a statistical tool for biotechnological applications: a critical appraisal | Q34758630 | ||
| Blocking primers to enhance PCR amplification of rare sequences in mixed samples - a case study on prey DNA in Antarctic krill stomachs | Q34797930 | ||
| KRAS mutations detected by the amplification refractory mutation system-Scorpion assays strongly correlate with therapeutic effect of cetuximab | Q35212649 | ||
| Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations | Q35877954 | ||
| An improved allele-specific PCR primer design method for SNP marker analysis and its application | Q36391841 | ||
| Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy | Q36610301 | ||
| KRAS and BRAF mutation analysis in colorectal adenocarcinoma specimens with a low percentage of tumor cells. | Q36872978 | ||
| Simple allele-discriminating PCR for cost-effective and rapid genotyping and mapping | Q37111992 | ||
| Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer | Q37378581 | ||
| High-sensitivity PCR method for detecting BRAF V600E mutations in metastatic colorectal cancer using LNA/DNA chimeras to block wild-type alleles | Q39026752 | ||
| ARMS-PCR for detection of BRAF V600E hotspot mutation in comparison with Real-Time PCR-based techniques | Q39185287 | ||
| Benign nodal nevi frequently harbor the activating V600E BRAF mutation | Q40025064 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. | Q40130589 | ||
| Sensitive detection of BRAF V600E mutation by Amplification Refractory Mutation System (ARMS)-PCR. | Q42176497 | ||
| Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer. | Q45376093 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 13817 | |
| P577 | publication date | 2017-10-23 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Improved detection of BRAF V600E using allele-specific PCR coupled with external and internal controllers | |
| P478 | volume | 7 |
Search more.